Gliosis in the spinal cord is increasingly recognized as a key mechanism of pain chronification, and CD11b and GFAP-expressing levels are generally used as biomarkers for microgliosis and astrogliosis, respectively [15]. The gene discussed is GFAP; the disease is Gliosis.